Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01363
|
|||||
| Drug Name |
Tolafentrine
|
|||||
| Synonyms |
BY-4070
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic obstructive pulmonary disease [ICD11: CA22] | Discontinued in Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C28H31N3O4S
|
|||||
| Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C3=NC4CCN(CC4C5=CC(=C(C=C53)OC)OC)C
|
|||||
| InChI |
InChI=1S/C28H31N3O4S/c1-18-5-11-21(12-6-18)36(32,33)30-20-9-7-19(8-10-20)28-23-16-27(35-4)26(34-3)15-22(23)24-17-31(2)14-13-25(24)29-28/h5-12,15-16,24-25,30H,13-14,17H2,1-4H3/t24-,25-/m0/s1
|
|||||
| InChIKey |
FVZJIAUYFDQQKJ-DQEYMECFSA-N
|
|||||
| CAS Number |
CAS 139308-65-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 505.6 | Topological Polar Surface Area | 88.6 | ||
| Heavy Atom Count | 36 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
4.1
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003767) | |||||
| 2 | A novel screening strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.